This article has been updated to include Enzo's R&D and SG&A costs for the quarter.

NEW YORK (GenomeWeb) – Enzo Biochem reported after the close of the market Monday that its second quarter revenues rose 7 percent year over year.

For the three months ended Jan. 31, the company reported revenues of $26.3 million, up from $24.6 million in Q2 2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.